LB Pharmaceuticals Inc. has granted Kaya Pai Panandiker, the new Chief Commercial Officer, an option to purchase 195,000 shares of the company's common stock. The stock option has a ten-year term with an exercise price of $21.36 per share, matching the closing price on the grant date. The option will vest over four years, with 25% vesting on the first anniversary of the grant and the remaining shares vesting in equal monthly installments thereafter, contingent on continued service.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LB Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9600373) on December 10, 2025, and is solely responsible for the information contained therein.